This randomized controlled trial followed 1,567 Norwegian community-dwelling adults aged 70-75 years for 60 months. Participants were assigned to high-intensity interval training (HIIT, n=400), moderate-intensity continuous training (MICT, n=387), or a control group following national physical activity guidelines (CON, n=780). The population was relatively healthy, with 86%-90% reporting good/very good health at baseline.
HIIT demonstrated benefits across several sarcopenia-related outcomes. Compared to control, HIIT was associated with less decline in grip strength at Year 1 (estimated difference 0.98 kg, p<0.001) and Year 3 (0.03 kg, p=0.016). At Year 3, HIIT showed increased gait speed versus control (estimated difference 0.03 m/s, p=0.016), though all groups declined from baseline by Year 5. Most notably, odds of developing clinically defined sarcopenia were lower for HIIT versus control at Year 3 (OR=0.51, p=0.018) and Year 5 (OR=0.47, p=0.009). Prevalence at Year 5 was 56% for HIIT versus 63% for control. No significant effects were found for MICT compared to control.
Safety and tolerability data were not reported. The study employed intention-to-treat analysis with p-values adjusted using Benjamini-Hochberg correction, supporting the robustness of findings. Key limitations include the relatively healthy population, which may limit generalizability to frailer older adults, and lack of reported adherence data. The absence of safety reporting warrants caution in clinical application.
While the RCT design supports causal inference, these results should be interpreted within the context of a specific, healthy Norwegian cohort. HIIT appears promising for long-term preservation of muscle function and reduction of sarcopenia risk in older adults who can tolerate higher-intensity exercise, though individual assessment of suitability remains essential.
View Original Abstract ↓
BACKGROUND: Early prevention of sarcopenia through exercise is vital to health, independence and mortality risk in older adults; however, there is a scarcity of evidence concerning the long-term effects of aerobic exercise alone. We tested the primary hypothesis that a 5-year decline in key defining components of sarcopenia is less in an aerobic exercise group compared with a control group. Secondly, we tested the same hypothesis using a model of 'clinically defined sarcopenia'.
METHODS: Norwegian community dwelling older adults (n = 1567; aged 70-75 years at inclusion) participated in the Generation 100 Study. They were randomized in a 1:1:2 ratio-stratified by sex and cohabitation status to either moderate intensity continuous training (MICT, n = 387) or high intensity interval training (HIIT, n = 400), or to a control group following the Norwegian physical activity guidelines (CON, n = 780). Key defining components of sarcopenia were grip strength (kilograms), skeletal muscle index (kg/m) and gait speed (m/s). Clinically defined sarcopenia was based on the European Working Group on Sarcopenia in Older People and recent normative data for the Norwegian population. An intention to treat linear mixed model and an ordinal logistic regression mixed model were used to examine the effects of aerobic exercise on sarcopenia on the 1, 3 and 5 years follow-up. p values for the main hypothesis were adjusted using the Benjamini-Hochberg correction.
RESULTS: Mean age across groups was 72 years of age, including ~50% women, ~50% with higher education, 86%-90% with good or very good health and 73%-76% considered physically active. Compared with CON, grip strength declined less for HIIT at Year 1 (estimated difference of 0.98 kg; p < 0.001) and Year 3 (estimated difference of 0.03 kg; p = 0.016). At Year 3, HIIT increased their gait speed by 0.01 m/s (estimated difference between HIIT vs. CON of 0.03 m/s; p = 0.016). At Year 5, all groups declined from baseline (CON -0.07; MICT -0.10 and HIIT -0.04 m/s). Participants determined as having 'clinically defined sarcopenia' at baseline, Years 3 and 5 were: 22%, 58% and 63% (CON); 20%, 55% and 67% (MICT) and 19%, 50% and 56% (HIIT). Odds for developing clinically defined sarcopenia were significantly lower for HIIT (OR = 0.51; p = 0.018 at Year 3; OR = 0.47; p = 0.009 at Year 5) as compared with CON. No effects were found for MICT.
CONCLUSIONS: The study demonstrates that in addition to having a protective cardiovascular effect, HIIT also has a beneficial effect on muscle strength and physical performance in a relatively healthy population of older adults.